Atossa Therapeutics (ATOS) Invested Capital (2011 - 2014)
Atossa Therapeutics (ATOS) posted quarterly Invested Capital of $3385.0 for Q3 2014, down 99.16% year-over-year from $402840.0 in Q3 2013, and down 71.86% quarter-over-quarter from $12028.0 in Q2 2014.
Atossa Therapeutics (ATOS) Invested Capital (2011 - 2014) Analysis & Trends
Atossa Therapeutics (ATOS) has reported Invested Capital for 4 consecutive years, with $3385.0 the latest figure, recorded in Q3 2014.
- In Q3 2014, Invested Capital fell 99.16% year-over-year to $3385.0; the TTM figure through Jun 2015 stood at $3385.0 (down 99.53% YoY), while the FY2013 annual figure was $211493.0, changed N/A from the prior year.
- Invested Capital retreated to $3385.0 in Q3 2014 per ATOS's latest filing, from $12028.0 in the prior quarter.
- Across five years, Invested Capital topped out at $1.0 million in Q4 2011 and bottomed at $3385.0 in Q3 2014.
- Historically, Invested Capital has averaged $282278.1 across 4 years, with a median of $211493.0 in 2013.
- Annual changes were most pronounced in 2013 — Invested Capital soared 61.14% — and 2014, when it sank 99.16%.
- Atossa Therapeutics' Invested Capital stood at $1.0 million in 2011, then slumped by 75.0% to $250000.0 in 2012, then dropped by 15.4% to $211493.0 in 2013, then plunged by 98.4% to $3385.0 in 2014.
- Business Quant data shows ATOS's Invested Capital at $3385.0 in Q3 2014, $12028.0 in Q2 2014, and $96201.0 in Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Atossa Therapeutics | 22.63 Mn | 22.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 3,385.00 |
| Jun 30, 2014 | 12,028.00 |
| Mar 31, 2014 | 96,201.00 |
| Dec 31, 2013 | 211,493.00 |
| Sep 30, 2013 | 402,840.00 |
| Sep 30, 2012 | 250,000.00 |
| Dec 31, 2011 | 1.00 Mn |